國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 861339      Online Users : 360
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Periodical Articles [42/42]

    Collection Statistics

    Item counts issued in 3 years:0(0.00%)
    Items With Fulltext:7(53.85%)

    Download counts of the item
    Download times greater than 0:7(100.00%)
    Download times greater than 100:7(100.00%)
    Total Bitstream Download Counts:4175(18.24%)

    Last Update: 2024-11-28 18:57


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-13 of 13. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DateTitleRelation
    2019-07 Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216 Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 4626.
    2019-05 A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534.
    2018-12 Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines Cancer Science. 2018 Dec;109(Suppl. 2):386.
    2018-07 Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 3944.
    2018-07 4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 1664.
    2018-07 Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4789.
    2016-12 Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84.
    2015-08 Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180.
    2015-05 Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
    2014-11 Cytokine induces MIR-424 expression and modulates SOCS2/STAT5 signaling pathway in oral cancer European Journal of Cancer. 2014 Nov;50(Suppl. 6):147.
    2014-11 Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
    2014-10 Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753.
    2014-05 High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.

    Showing items 1-13 of 13. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback